BIOMAT Database Logo BIOMAT Database Logo

Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues. 1998

O Lavergne, and L Lesueur-Ginot, and F Pla Rodas, and P G Kasprzyk, and J Pommier, and D Demarquay, and G Prévost, and G Ulibarri, and A Rolland, and A M Schiano-Liberatore, and J Harnett, and D Pons, and J Camara, and D C Bigg
Institut Henri Beaufour, 5, avenue du Canada, F-91966 Les Ulis, France.

Homocamptothecin (hCPT), a camptothecin (CPT) analogue with a seven membered beta-hydroxylactone which combines enhanced plasma stability and potent topoisomerase I (Topo I)-mediated activity, is an attractive template for the elaboration of new anticancer agents. Like CPT, hCPT carries an asymmetric tertiary alcohol and displays stereoselective inhibition of Topo I. The preparation and biological screening of racemic hCPT analogues are described. The 10 hCPTs tested were better Topo I inhibitors than CPT. Fluorinated hCPTs 23c, d,f,g were found to have potent cytotoxic activity on A427 and PC-3 tumor cell lines. Their cytotoxicity remained high on the K562adr and MCF7mdr cell lines, which overexpress a functionally active P-glycoprotein. Fluorinated hCPTs were more efficacious in vivo than CPT on HT-29 xenografts. In this model, a tumor growth delay of 25 days was reached with hCPT 23g at a daily dose of 0.32 mg/kg, compared to 4 days with CPT at 0.625 mg/kg. Thus difluorinated hCPT 23g warrants further investigation as a novel Topo I inhibitor with high cytotoxicity toward tumor cells and promising in vivo efficacy.

UI MeSH Term Description Entries
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

O Lavergne, and L Lesueur-Ginot, and F Pla Rodas, and P G Kasprzyk, and J Pommier, and D Demarquay, and G Prévost, and G Ulibarri, and A Rolland, and A M Schiano-Liberatore, and J Harnett, and D Pons, and J Camara, and D C Bigg
Homocamptothecins: E-ring modified CPT analogues.
January 2000, Annals of the New York Academy of Sciences,
O Lavergne, and L Lesueur-Ginot, and F Pla Rodas, and P G Kasprzyk, and J Pommier, and D Demarquay, and G Prévost, and G Ulibarri, and A Rolland, and A M Schiano-Liberatore, and J Harnett, and D Pons, and J Camara, and D C Bigg
Antitumor agents. V. Synthesis and antileukemic activity of E-ring-modified (RS)-camptothecin analogues.
March 1992, Chemical & pharmaceutical bulletin,
O Lavergne, and L Lesueur-Ginot, and F Pla Rodas, and P G Kasprzyk, and J Pommier, and D Demarquay, and G Prévost, and G Ulibarri, and A Rolland, and A M Schiano-Liberatore, and J Harnett, and D Pons, and J Camara, and D C Bigg
Synthesis and antitumor activity of A-ring modified hexacyclic analogues of camptothecin.
March 2005, Yao xue xue bao = Acta pharmaceutica Sinica,
O Lavergne, and L Lesueur-Ginot, and F Pla Rodas, and P G Kasprzyk, and J Pommier, and D Demarquay, and G Prévost, and G Ulibarri, and A Rolland, and A M Schiano-Liberatore, and J Harnett, and D Pons, and J Camara, and D C Bigg
Plant antitumor agents. 29. Synthesis and biological activity of ring D and ring E modified analogues of camptothecin.
March 1990, Journal of medicinal chemistry,
O Lavergne, and L Lesueur-Ginot, and F Pla Rodas, and P G Kasprzyk, and J Pommier, and D Demarquay, and G Prévost, and G Ulibarri, and A Rolland, and A M Schiano-Liberatore, and J Harnett, and D Pons, and J Camara, and D C Bigg
Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.
June 1998, Journal of medicinal chemistry,
O Lavergne, and L Lesueur-Ginot, and F Pla Rodas, and P G Kasprzyk, and J Pommier, and D Demarquay, and G Prévost, and G Ulibarri, and A Rolland, and A M Schiano-Liberatore, and J Harnett, and D Pons, and J Camara, and D C Bigg
Synthesis and antitumor activity of novel 20s-camptothecin analogues.
January 2009, Bioorganic & medicinal chemistry letters,
O Lavergne, and L Lesueur-Ginot, and F Pla Rodas, and P G Kasprzyk, and J Pommier, and D Demarquay, and G Prévost, and G Ulibarri, and A Rolland, and A M Schiano-Liberatore, and J Harnett, and D Pons, and J Camara, and D C Bigg
Synthesis and antitumor activity of novel 10-substituted camptothecin analogues.
November 2006, Bioorganic & medicinal chemistry,
O Lavergne, and L Lesueur-Ginot, and F Pla Rodas, and P G Kasprzyk, and J Pommier, and D Demarquay, and G Prévost, and G Ulibarri, and A Rolland, and A M Schiano-Liberatore, and J Harnett, and D Pons, and J Camara, and D C Bigg
Antitumor agents. 7. Synthesis and antitumor activity of novel hexacyclic camptothecin analogues.
September 1994, Journal of medicinal chemistry,
O Lavergne, and L Lesueur-Ginot, and F Pla Rodas, and P G Kasprzyk, and J Pommier, and D Demarquay, and G Prévost, and G Ulibarri, and A Rolland, and A M Schiano-Liberatore, and J Harnett, and D Pons, and J Camara, and D C Bigg
Synthesis and biological evaluation of novel A-ring modified hexacyclic camptothecin analogues.
May 2001, Journal of medicinal chemistry,
O Lavergne, and L Lesueur-Ginot, and F Pla Rodas, and P G Kasprzyk, and J Pommier, and D Demarquay, and G Prévost, and G Ulibarri, and A Rolland, and A M Schiano-Liberatore, and J Harnett, and D Pons, and J Camara, and D C Bigg
Synthesis and antitumor activity of 20(S)-camptothecin derivatives. A-ring-substituted 7-ethylcamptothecins and their E-ring-modified water-soluble derivatives.
December 1994, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!